59
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

Response to “Clinical implications of assay-specific differences in f-calprotectin when monitoring inflammatory bowel disease activity over time”

References

  • Amcoff K, Stridsberg M, Lampinen M, et al. Clinical implications of assay specific differences in f-Calprotectin when monitoring inflammatory bowel disease activity over time. Scand J Gastroenterol. 2017;52:344–350.
  • Pavlidis P, Chedgy F, Tibble J. Diagnostic accuracy and clinical application of faecal calprotectin in adult patients presenting with gastrointestinal symptoms in primary care. Scand J Gastroenterol. 2013;48:1048–1054.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.